A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 99.62
GOOG 725.27
MSFT 52.12
FB 117.89
BAC 14.92

Recently Added

CIX 11.60
ZBH 121.93
PPCH 0.02
SPHS 0.93
GAIN 6.98

Gaining Speed

CIX 11.60
SPHS 0.93
PPCH 0.02
ZBH 121.93
MJNA 0.05

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More




Get Alerted When News Hits On This Stock - FREE!